← FDA Drug Approvals (Drugs@FDA)

ALCAFTADINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2024-10-02

Drug application

FDA Application #

ANDA209290

Application type

Abbreviated New Drug Application (Generic)

Brand name

ALCAFTADINE

Generic name

ALCAFTADINE

Active ingredients

ALCAFTADINE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Over-the-counter

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2024-10-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown